Abstract:Search for new biologically active compounds includes the directed design of molecules based on the so-called structural blocks – usually the privileged (structures, to which the 4-thiazolidinone cycle belongs. Therefore the development of methods for the synthesis of small "drug-like" molecules from 2-cyanomethylidene-4-thiazolidinone group as well as the study of their biological profile is an urgent task for modern medicinal chemistry. Aim. To design and to the synthesis of novel 5-ylidene derivatives of 2-cyano-2-(4-oxo-3-phenylthiazolidin-2-ylidene)- N -arylacetamides. Study of the antitumor activity of synthesized compounds. Materials and methods . Organic synthesis, study of the spectral characteristics of obtained 4-thiazolidinones ( 1 H and 13 C NMR spectroscopy, LC- MS spectrometry). In vitro antitumor activity study according to the DTP Program of the National Cancer Institute (USA). Results. A number of 5-substituted 2-cyano-2-(4-oxo-3-phenylthiazolidin-2-ylidene)- N -arylacetamide derivatives had been synthesized. The structure and purity of the synthesized compounds were confirmed by the methods of elemental analysis, 1 H, 13 C NMR spectroscopy and LC-MS. The antitumor activity of some of the synthesized compounds was investigated on a panel of 59 human tumor cell lines representing nine neoplastic diseases. Conclusions. Based on the C5 modification of the methylene group of the 4-thiazolidinone cycle, the target 5-ylidene and 5-aminomethylene-2-cyano-2-(4-oxo-3-phenylthiazolidin-2-ylidene)- N -arylacetamides had been synthesized. A hit-compound 2-cyano-2-[5-[(4-methoxyphenyl)methylene]-4-oxo-3-phenylthiazolidin-2-ylidene]- N -arylacetamide was identified that selectively inhibited the growth of some cell lines of CNS, kidney and breast cancers.

Design and synthesis of 5-azacytidine analogs

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Solvent-free Synthesis of 5-Azacytosine with Microwave Activation

Synthesis and Biological Research of Novel Azaacridine Derivatives As Potent DNA-binding Ligands and Topoisomerase II Inhibitors

Synthesis and anticancer activity of 2-cyano-2-(4-oxo-3-phenylthiazolidin-2-ylidene)-N-arylacetamides

Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents.

Design, Synthesis and Anticancer Evaluation of Acridine Hydroxamic Acid Derivatives As Dual Topo and HDAC Inhibitors.

Design, synthesis and anticancer activity of 5-aryl-4-(4-arylpiperazine-1-carbonyl)-1,2,3-thiadiazoles as microtubule-destabilizing agents

Design, Synthesis, and Antitumor Activity of Bile Acid–polyamine–nucleoside Conjugates

Recent Advances in the Chemical Synthesis and Evaluation of Anticancer Nucleoside Analogues

Design, Synthesis and Biological Evaluation of N-arylphenyl-2,2-dichloroacetamide Analogues As Anti-Cancer Agents.

Novel Aryltriazole Acyclic C-azanucleosides As Anticancer Candidates

Design, Synthesis and Antiproliferative Activity of Novel 5-Nitropyrimidine-2,4-diamine Derivatives Bearing Alkyl Acetate Moiety

Design, Synthesis and Preliminary Antiproliferative Activity Studies of New Diheteroaryl Thioether Derivatives

An Improved Approach for Practical Synthesis of 5-Hydroxymethyl-2′-deoxycytidine (5hmdC) Phosphoramidite and Triphosphate

Design, Synthesis, and Molecular Docking Studies of New Quinoline-Thiazole Hybrids, Potential Leads in the Development of Novel Antileukemic Agents

Design, Synthesis and Anticancer Potential of NSC-319745 Hydroxamic Acid Derivatives As DNMT and HDAC Inhibitors

Design and Synthesis of 7-Azaindole Derivatives As Potent CDK8 Inhibitors for the Treatment of Acute Myeloid Leukemia

Acridine and its derivatives: a patent review (2009 - 2013).

Design, Synthesis, and Activity Evaluation of Novel Acyclic Nucleosides as Potential Anticancer Agents <i>In Vitro</i> and <i>In Vivo</i>

Synthesis and Anticancer Research ofN-(2-aminophenyl)benzamide Acridine Derivatives as Dual Topoisomerase I and Isoform-Selective HDAC Inhibitors